Filing Details

Accession Number:
0001144204-19-038365
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-08 06:15:30
Reporting Period:
2019-08-06
Accepted Time:
2019-08-08 06:15:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1723128 Amneal Pharmaceuticals Inc. AMRX () K3
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1447884 Ltd International Fosun Room 808, Icbc Tower
3 Garden Road, Central
Hong Kong K3 00000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2019-08-06 327,000 $2.91 327,000 No 4 P Indirect by Peak Reinsurance Company Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect by Peak Reinsurance Company Limited
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 1,642,300 Indirect by Fosun Atlas Capital SICAV RAIF S.C.S.
Class A Common Stock 16,438,356 Indirect by Ambient Impact (HK) Limited
Footnotes
  1. Peak Reinsurance Company Limited is a subsidiary of the Reporting Person.
  2. Fosun Atlas Capital SICAV RAIF S.C.S. is a fund managed by a wholly-owned subsidiary of the Reporting Person.
  3. Ambient Impact (HK) Limited is a wholly-owned subsidiary of the Reporting Person.